Humana (NYSE:HUM) Downgraded by StockNews.com to “Hold”

StockNews.com cut shares of Humana (NYSE:HUM) from a buy rating to a hold rating in a report published on Wednesday morning.

HUM has been the topic of several other reports. Morgan Stanley cut their price objective on shares of Humana from $301.00 to $285.00 and set an “equal weight” rating on the stock in a research report on Wednesday, February 12th. Piper Sandler lifted their price objective on shares of Humana from $270.00 to $288.00 and gave the company a “neutral” rating in a research report on Wednesday, January 15th. Barclays lifted their price objective on shares of Humana from $255.00 to $270.00 and gave the company an “equal weight” rating in a research report on Thursday, February 13th. Truist Financial lifted their price objective on shares of Humana from $260.00 to $290.00 and gave the company a “hold” rating in a research report on Monday, January 6th. Finally, JPMorgan Chase & Co. dropped their price target on shares of Humana from $257.00 to $256.00 and set a “neutral” rating on the stock in a research report on Tuesday, February 18th. Twenty analysts have rated the stock with a hold rating and five have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, Humana currently has a consensus rating of “Hold” and an average target price of $285.68.

Humana Trading Down 0.3 %

NYSE HUM opened at $262.10 on Wednesday. Humana has a one year low of $213.31 and a one year high of $406.46. The company has a 50-day simple moving average of $271.53 and a 200-day simple moving average of $284.92. The company has a debt-to-equity ratio of 0.68, a quick ratio of 1.76 and a current ratio of 1.76. The firm has a market capitalization of $31.62 billion, a PE ratio of 26.34, a price-to-earnings-growth ratio of 2.05 and a beta of 0.57.

Humana (NYSE:HUM) last issued its quarterly earnings data on Tuesday, February 11th. The insurance provider reported ($2.16) earnings per share for the quarter, beating the consensus estimate of ($2.26) by $0.10. Humana had a net margin of 1.02% and a return on equity of 11.70%. On average, equities analysts forecast that Humana will post 16.47 earnings per share for the current year.

Humana Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, April 25th. Investors of record on Friday, March 28th will be issued a $0.885 dividend. The ex-dividend date of this dividend is Friday, March 28th. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.35%. Humana’s payout ratio is currently 35.58%.

Insider Buying and Selling

In related news, insider Timothy S. Huval sold 3,703 shares of the business’s stock in a transaction that occurred on Tuesday, December 31st. The shares were sold at an average price of $256.26, for a total value of $948,930.78. Following the sale, the insider now directly owns 8,181 shares in the company, valued at $2,096,463.06. The trade was a 31.16 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Insiders own 0.32% of the company’s stock.

Institutional Inflows and Outflows

Several institutional investors have recently made changes to their positions in HUM. Creative Financial Designs Inc. ADV increased its position in shares of Humana by 244.0% in the third quarter. Creative Financial Designs Inc. ADV now owns 86 shares of the insurance provider’s stock worth $27,000 after acquiring an additional 61 shares in the last quarter. Janney Montgomery Scott LLC increased its position in shares of Humana by 11.6% in the third quarter. Janney Montgomery Scott LLC now owns 3,721 shares of the insurance provider’s stock worth $1,179,000 after acquiring an additional 388 shares in the last quarter. Van ECK Associates Corp purchased a new position in shares of Humana in the third quarter worth approximately $424,000. Robeco Institutional Asset Management B.V. increased its position in shares of Humana by 44.7% in the third quarter. Robeco Institutional Asset Management B.V. now owns 11,162 shares of the insurance provider’s stock worth $3,535,000 after acquiring an additional 3,447 shares in the last quarter. Finally, Asset Management One Co. Ltd. increased its position in shares of Humana by 0.5% in the third quarter. Asset Management One Co. Ltd. now owns 54,428 shares of the insurance provider’s stock worth $17,240,000 after acquiring an additional 276 shares in the last quarter. 92.38% of the stock is owned by hedge funds and other institutional investors.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.